Literature DB >> 23002360

Clinical usefulness of adherence to gastro-esophageal reflux disease guideline by Spanish gastroenterologists.

Fermín Mearin1, Julio Ponce, Marta Ponce, Agustín Balboa, Miguel A González, Javier Zapardiel.   

Abstract

AIM: To investigate usefulness of adherence to gastro-esophageal reflux disease (GERD) guideline established by the Spanish Association of Gastroenterology.
METHODS: Prospective, observational and multicentre study of 301 patients with typical symptoms of GERD who should be managed in accordance with guidelines and were attended by gastroenterologists in daily practice. Patients (aged > 18 years) were eligible for inclusion if they had typical symptoms of GERD (heartburn and/or acid regurgitation) as the major complaint in the presence or absence of accompanying atypical symptoms, such as dyspeptic symptoms and/or supraesophageal symptoms. Diagnostic and therapeutic decisions should be made based on specific recommendations of the Spanish clinical practice guideline for GERD which is a widely disseminated and well known instrument among Spanish in digestive disease specialists.
RESULTS: Endoscopy was indicated in 123 (41%) patients: 50 with alarm symptoms, 32 with age > 50 years without alarm symptom. Seventy-two patients (58.5%) had esophagitis (grade A, 23, grade B, 28, grade C, 18, grade D, 3). In the presence of alarm symptoms, endoscopy was indicated consistently with recommendations in 98% of cases. However, in the absence of alarm symptoms, endoscopy was indicated in 33% of patients > 50 years (not recommended by the guideline). Adherence for proton pump inhibitors (PPIs) therapy was 80%, but doses prescribed were lower (half) in 5% of cases and higher (double) in 15%. Adherence regarding duration of PPI therapy was 69%; duration was shorter than recommended in 1% (4 wk in esophagitis grades C-D) or longer in 30% (8 wk in esophagitis grades A-B or in patients without endoscopy). Treatment response was higher when PPI doses were consistent with guidelines, although differences were not significant (95% vs 85%).
CONCLUSION: GERD guideline compliance was quite good although endoscopy was over indicated in patients > 50 years without alarm symptoms; PPIs were prescribed at higher doses and longer duration.

Entities:  

Keywords:  Adherence to guidelines; Clinical practice guidelines; Gastro-esophageal reflux disease; Treatment of gastro-esophageal reflux disease

Mesh:

Substances:

Year:  2012        PMID: 23002360      PMCID: PMC3447270          DOI: 10.3748/wjg.v18.i35.4885

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Successes and failures in the implementation of evidence-based guidelines for clinical practice.

Authors:  R Grol
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

2.  Are dyspepsia management guidelines coherent with primary care practice?

Authors:  F Cardin; M Zorzi; A Furlanetto; C Guerra; F Bandini; D Polito; F Bano; A M Grion; R Toffanin
Journal:  Scand J Gastroenterol       Date:  2002-11       Impact factor: 2.423

3.  Gastro-oesophageal reflux disease in adults: Guidelines for clinicians.

Authors:  Peter Katelaris; Richard Holloway; Nicholas Talley; David Gotley; Steven Williams; John Dent
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

4.  Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain.

Authors:  E Rey; C Moreno Elola-Olaso; F Rodríguez Artalejo; M Díaz-Rubio
Journal:  Rev Esp Enferm Dig       Date:  2006-07       Impact factor: 2.086

5.  Concordance between use of proton pump inhibitors and prescribing guidelines.

Authors:  P I Pillans; P A Kubler; J M Radford; V Overland
Journal:  Med J Aust       Date:  2000-01-03       Impact factor: 7.738

6.  Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline.

Authors:  E A Halm; S J Atlas; L H Borowsky; T I Benzer; D E Singer
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

7.  Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.

Authors:  F Pace; C Negrini; I Wiklund; C Rossi; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2005-08-15       Impact factor: 8.171

Review 8.  Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia.

Authors:  A P S Hungin; C Hill; A Raghunath
Journal:  Aliment Pharmacol Ther       Date:  2009-08-15       Impact factor: 8.171

Review 9.  Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management.

Authors:  JoaquimPradoP Moraes-Filho; Ivan Cecconello; Joaquim Gama-Rodrigues; LuizdePaula Castro; Maria Aparecida Henry; Ulisses G Meneghelli; Eamonn Quigley
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 10.  Review of the quality of life and burden of illness in gastroesophageal reflux disease.

Authors:  Ingela Wiklund
Journal:  Dig Dis       Date:  2004       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.